Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Outcomes Research Consortium, Cleveland, OH, USA.
Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Br J Anaesth. 2020 Jul;125(1):25-37. doi: 10.1016/j.bja.2020.03.013. Epub 2020 May 29.
Finger cuff technologies allow continuous noninvasive arterial blood pressure (AP) and cardiac output/index (CO/CI) monitoring.
We performed a meta-analysis of studies comparing finger cuff-derived AP and CO/CI measurements with invasive measurements in surgical or critically ill patients. We calculated overall random effects model-derived pooled estimates of the mean of the differences and of the percentage error (PE; CO/CI studies) with 95%-confidence intervals (95%-CI), pooled 95%-limits of agreement (95%-LOA), Cochran's Q and I (for heterogeneity).
The pooled mean of the differences (95%-CI) was 4.2 (2.8 to 5.62) mm Hg with pooled 95%-LOA of -14.0 to 22.5 mm Hg for mean AP (Q=230.4 [P<0.001], I=91%). For mean AP, the mean of the differences between finger cuff technologies and the reference method was ≤5±8 mm Hg in 9/27 data sets (33%). The pooled mean of the differences (95%-CI) was -0.13 (-0.43 to 0.18) L min with pooled 95%-LOA of -2.56 to 2.23 L min for CO (Q=66.7 [P<0.001], I=90%) and 0.07 (0.01 to 0.13) L min m with pooled 95%-LOA of -1.20 to 1.15 L min m for CI (Q=5.8 [P=0.326], I=0%). The overall random effects model-derived pooled estimate of the PE (95%-CI) was 43 (37 to 49)% (Q=48.6 [P<0.001], I=63%). In 4/19 data sets (21%) the PE was ≤30%, and in 10/19 data sets (53%) it was ≤45%.
Study heterogeneity was high. Several studies showed interchangeability between AP and CO/CI measurements using finger cuff technologies and reference methods. However, the pooled results of this meta-analysis indicate that AP and CO/CI measurements using finger cuff technologies and reference methods are not interchangeable in surgical or critically ill patients.
PROSPERO registration number: CRD42019119266.
手指套技术可实现连续无创动脉血压(AP)和心输出量/指数(CO/CI)监测。
我们对比较手指套衍生的 AP 和 CO/CI 测量值与手术或危重症患者的有创测量值的研究进行了荟萃分析。我们计算了总体随机效应模型得出的差异平均值和百分比误差(PE;CO/CI 研究)的汇总估计值,以及 95%-置信区间(95%-CI)、汇总 95%-一致性界限(95%-LOA)、Cochran's Q 和 I(用于异质性)。
AP 的平均差异(95%-CI)汇总平均值为 4.2(2.8 至 5.62)mmHg,AP 的汇总 95%-LOA 为 -14.0 至 22.5 mmHg(Q=230.4[P<0.001],I=91%)。对于平均 AP,在 27 个数据集(33%)中的 9 个数据集中,手指套技术与参考方法之间的差异平均值小于等于 5±8 mmHg。CO 的差异平均值(95%-CI)为 -0.13(-0.43 至 0.18)L min,CO 的汇总 95%-LOA 为 -2.56 至 2.23 L min(Q=66.7[P<0.001],I=90%),CI 的差异平均值(95%-CI)为 0.07(0.01 至 0.13)L min m,CI 的汇总 95%-LOA 为 -1.20 至 1.15 L min m(Q=5.8[P=0.326],I=0%)。PE(95%-CI)的总体随机效应模型汇总估计值为 43(37 至 49)%(Q=48.6[P<0.001],I=63%)。在 19 个数据集(21%)中的 4 个数据集中,PE 小于等于 30%,在 19 个数据集(53%)中的 10 个数据集中,PE 小于等于 45%。
研究的异质性很高。一些研究表明,使用手指套技术和参考方法测量 AP 和 CO/CI 是可以互换的。然而,本荟萃分析的汇总结果表明,在手术或危重症患者中,使用手指套技术和参考方法测量 AP 和 CO/CI 是不可互换的。
PROSPERO 注册号:CRD42019119266。